Chemokine organization of tumor-associated tertiary lymphoid structures and the candidate roles of atypical receptors

Tumor-associated tertiary lymphoid structures (TLS) organize local adaptive immunity through chemokine-dependent encounters among B cells, T cells, dendritic cells and stromal cells. Their therapeutic relevance depends on which interactions they sustain, as well as their location and architecture. This critical narrative review links chemokine production and extracellular handling to follicular positioning, germinal-center activity and effector access. We examine the established CXCL13–CXCR5, CCL19/CCL21–CCR7, CXCL12–CXCR4 and CXCL9/10/11–CXCR3 axes alongside candidate roles for atypical chemokine receptors, CCRL2 and the proteoform modifier dipeptidyl peptidase 4. A claim-specific evidence map distinguishes mechanisms demonstrated in source systems, human tumor-TLS associations, tumor perturbations with TLS readouts and hypotheses awaiting direct testing. These evidence contexts are complementary rather than a hierarchy of study quality. The synthesis identifies where selective transport, scavenging, presentation or proteolysis could alter cellular positioning, and where current receptor–ligand assignments require biochemical resolution. Non-chemokine positioning cues, context-dependent CXCL13-producing T-cell programs and class-switch recombination broaden the interpretation of B-cell activity beyond germinal-center morphology. We then connect each candidate intervention to an intended immune function, available experimental or clinical tools and its principal mechanistic and safety uncertainties. This framework supports the design of spatially resolved perturbation studies that measure ligand handling before cell positioning and antigen-dependent output. Its translational value is to distinguish strategies for constructing a lymphoid niche from those that improve access to, or function within, an existing niche, while keeping patient benefit and off-tumor safety as separate outcomes.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-13
DOI
https://doi.org/10.3389/fimmu.2026.2010172
Primary Topic
Chemokine receptors and signaling
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Chemokine organization of tumor-associated tertiary lymphoid structures and the candidate roles of atypical receptors

Yao Tang, Wei Zhu, Pan Sun, Yan Zhang et al.
2 links
Frontiers in Immunology
Chemokine receptors and signaling
article

Chemokine organization of tumor-associated tertiary lymphoid structures and the candidate roles of atypical receptors

Yao Tang, Wei Zhu, Pan Sun, Yan Zhang, Juan Yang, Jinglin Wang
article en

Abstract

Tumor-associated tertiary lymphoid structures (TLS) organize local adaptive immunity through chemokine-dependent encounters among B cells, T cells, dendritic cells and stromal cells. Their therapeutic relevance depends on which interactions they sustain, as well as their location and architecture. This critical narrative review links chemokine production and extracellular handling to follicular positioning, germinal-center activity and effector access. We examine the established CXCL13–CXCR5, CCL19/CCL21–CCR7, CXCL12–CXCR4 and CXCL9/10/11–CXCR3 axes alongside candidate roles for atypical chemokine receptors, CCRL2 and the proteoform modifier dipeptidyl peptidase 4. A claim-specific evidence map distinguishes mechanisms demonstrated in source systems, human tumor-TLS associations, tumor perturbations with TLS readouts and hypotheses awaiting direct testing. These evidence contexts are complementary rather than a hierarchy of study quality. The synthesis identifies where selective transport, scavenging, presentation or proteolysis could alter cellular positioning, and where current receptor–ligand assignments require biochemical resolution. Non-chemokine positioning cues, context-dependent CXCL13-producing T-cell programs and class-switch recombination broaden the interpretation of B-cell activity beyond germinal-center morphology. We then connect each candidate intervention to an intended immune function, available experimental or clinical tools and its principal mechanistic and safety uncertainties. This framework supports the design of spatially resolved perturbation studies that measure ligand handling before cell positioning and antigen-dependent output. Its translational value is to distinguish strategies for constructing a lymphoid niche from those that improve access to, or function within, an existing niche, while keeping patient benefit and off-tumor safety as separate outcomes.

Frontiers in ImmunologyVol. 17
Affiliated Hospital of Guizhou Medical University (CN), Guizhou Provincial People's Hospital (CN)
National Natural Science Foundation of China
Good health and well-being
Chemokine receptors and signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon